Active Biotech AB (publ) (ACTI.ST)
SEK 0.11
(-7.32%)
SEK 0.11
(-7.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -45.8 Million | -54.85 Million | -46.16 Million | -32.21 Million | -35.81 Million | -40.64 Million |
| Net Income | -45.8 Million | -58.37 Million | -49.82 Million | -32.24 Million | -34.13 Million | -36.87 Million |
| Depreciation & Amortization | 1.7 Million | 1.49 Million | 1.27 Million | 1.32 Million | 867 Thousand | 447 Thousand |
| Deferred income taxes | -3.57 Million | -2.34 Million | -745 Thousand | -5.08 Million | - | - |
| Stock-based compensation | 172 Thousand | 690 Thousand | 284 Thousand | 576 Thousand | - | - |
| Change in working capital | -1.8 Million | 1.33 Million | 2.09 Million | -1.86 Million | -2.54 Million | -4.21 Million |
| Other non-cash items | -72 Thousand | 2.34 Million | 745 Thousand | 5.08 Million | 4.28 Million | 5.11 Million |
| Investing Cash Flow | - | -245 Thousand | - | - | 275 Million | - |
| Investments in PPE | - | -245 Thousand | - | - | - | - |
| Acquisitions | - | - | - | - | 275 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -245.00 | - | - | 275 Thousand | - |
| Financing Cash Flow | 40.16 Thousand | 43.75 Million | 73.08 Million | -1.25 Million | -205.05 Million | 41.04 Thousand |
| Debt repayment | -1621.00 | -1762.00 | -1015.00 | -1252.00 | -204.05 Million | -6069.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 41.78 Million | 46.83 Million | 76.24 Million | - | - | 47.11 Million |
| Other Financing Activities | 41.78 Thousand | -3.07 Million | -3.16 Million | -1.25 Million | -1 Million | 47.11 Thousand |
| Accounts receivables | -168 Thousand | 26 Thousand | 993 Thousand | 11 Thousand | -2.3 Million | 1.33 Million |
| Accounts payables | -1.62 Million | 1.31 Million | 1.1 Million | -1.87 Million | -248 Thousand | -5.55 Million |
| Inventory | - | -1311.00 | -1104.00 | 1878.00 | 248.00 | - |
| Other working capital | -1.8 Million | 1311.00 | 1104.00 | -1878.00 | -248.00 | -5551.00 |
| Cash at beginning of period | 41.79 Million | 53.13 Million | 26.21 Million | 59.68 Million | 25.55 Million | 25.15 Million |
| Cash at end of period | 36.2 Million | 41.79 Million | 53.13 Million | 26.21 Million | 59.68 Million | 25.55 Million |
| Capital Expenditure | - | -245 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.59 Million | -11.33 Million | 26.92 Million | -33.46 Million | 34.12 Million | 400 Thousand |
| Free Cash Flow | -45.8 Million | -55.09 Million | -46.16 Million | -32.21 Million | -35.81 Million | -40.64 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8 Million | -10.6 Million | -10.5 Million | -12.5 Million | -45.8 Million | -10.6 Million |
| Depreciation & Amortization | 400 Thousand | 400 Thousand | 400 Thousand | 400 Thousand | 1.7 Million | 400 Thousand |
| Deferred income taxes | - | - | - | - | -3.57 Million | - |
| Stock-based compensation | - | - | - | 172.00 | 172 Thousand | - |
| Change in working capital | 400 Thousand | -900 Thousand | -300 Thousand | 1.2 Million | -1.8 Million | 500 Thousand |
| Other non-cash items | 400 Thousand | 900 Thousand | 700 Thousand | 800 Thousand | -72 Thousand | 100 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -400 Thousand | -400 Thousand | -400 Thousand | 41.46 Thousand | 40.16 Thousand | -500.00 |
| Debt repayment | -400 Thousand | -400 Thousand | -400 Thousand | -421.00 | -1621.00 | -400.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -100 Thousand | - | - | 41.88 Million | 41.78 Million | -100 Thousand |
| Other Financing Activities | 100 Thousand | - | - | 41.88 Thousand | 41.78 Thousand | -100.00 |
| Accounts receivables | - | - | - | -168.00 | -168 Thousand | - |
| Accounts payables | - | - | - | - | -1.62 Million | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 400 Thousand | -900 Thousand | -300.00 | 1.2 Million | -1.8 Million | 500 Thousand |
| Cash at beginning of period | 13.9 Million | 25.4 Million | 36.21 Million | 5.6 Million | 41.79 Million | 15.7 Million |
| Cash at end of period | 6.2 Million | 13.9 Million | 25.4 Million | 36.2 Million | 36.2 Million | 5.6 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -7.7 Million | -11.5 Million | -10.81 Million | 30.6 Million | -5.59 Million | -10.1 Million |
| Free Cash Flow | -7.2 Million | -11 Million | -10.5 Million | -10.9 Million | -45.8 Million | -9.6 Million |
RTEN
AVOL
ORSTED
ST1
600602
SAN